Need more info, can’t cut corners on Covaxin: WHO
The WHO said on Monday it was “aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the Covid-19 emergency use listing (EUL)” but that it “cannot cut corners”. It added that “before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective”.
💡 newsR Knowledge: Other News Mentions
India willing to supply Covishield, Covaxin: Mandaviya to Latin American, Caribbean envoysInteracting with ambassadors of Latin American and Caribbean nations, Union Health Minister Mansukh Mandaviya on Thursday said India is willing to supply..
Covaxin provides only 50 percent protection against Covid-19, says The Lancet | Oneindia News
Credit: Oneindia Duration: 02:34Published
Lancet Infectious Diseases study compare well with phase 3 clinical trials of Covaxin: Bharat BiotechCommenting on the study of the Lancet Infectious Diseases on the effectiveness of Covaxin (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech..
India’s Covaxin gave lower protection in Delta waveTwo doses of Covaxin are 50 per cent effective against symptomatic Covid-19, according to the first real-world assessment of India's indigenous coronavirus..
Covaxin shows 50% effectiveness against symptomatic Covid-19 in real-world assessment: Lancet studyTwo doses of Covaxin are 50 per cent effective against symptomatic Covid-19, according to the first real-world assessment of India's indigenous coronavirus..
You Might Like
Related news from verified sources